July 28, 2025 · Form 4 insider transaction
Smith Jason Drew bought 16,500 shares of UROGEN PHARMA LTD, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event.; Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.